23 Mar Management of Patients Treated with Direct Oral Anticoagulants – the Clinical Laboratory Perspective
By: ARMANDO TRIPODI, PH.D. Direct oral anticoagulants (DOACs) targeting activated coagulation factors have been developed and compared to low molecular weight heparins (LMWH) in patients undergoing orthopaedic surgery, for their efficacy and safety, and with warfarin in patients with venous thromboembolism or atrial fibrillation. Cumulatively, clinical trials have...
